{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:32:15Z","timestamp":1793284335478,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL158517"],"award-info":[{"award-number":["R01 HL158517"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL160761"],"award-info":[{"award-number":["R01 HL160761"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL162830"],"award-info":[{"award-number":["R01 HL162830"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.ahj.2026.107589","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:51:37Z","timestamp":1787673097000},"page":"107589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Guideline-directed medical therapy and clinical outcomes in adults with Fontan palliation and systemic ventricular systolic dysfunction"],"prefix":"10.1016","volume":"303","author":[{"given":"Alexander C.","family":"Egbe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaaeldin","family":"Hodhod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Rashwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed T.","family":"Abdelhalim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Moustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naser","family":"Ammash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2026.107589_bib0001","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/thx.26.3.240","article-title":"Surgical repair of tricuspid atresia","volume":"26","author":"Fontan","year":"1971","journal-title":"Thorax"},{"key":"10.1016\/j.ahj.2026.107589_bib0002","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0022-5223(19)35174-8","article-title":"Total cavopulmonary connection: a logical alternative to atriopulmonary connection for complex Fontan operations. Experimental studies and early clinical experience","volume":"96","author":"de Leval","year":"1988","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ahj.2026.107589_bib0003","article-title":"Temporal change in the age at time of death in adults with congenital heart disease","volume":"20","author":"Kholeif","year":"2025","journal-title":"Int J Cardiol Congenit Heart Dis"},{"key":"10.1016\/j.ahj.2026.107589_bib0004","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/CIRCULATIONAHA.115.017202","article-title":"Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre","volume":"132","author":"Diller","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107589_bib0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.107.738559","article-title":"Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery","volume":"117","author":"Khairy","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107589_bib0006","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/heartjnl-2015-307467","article-title":"The Fontan circulation after 45 years: update in physiology","volume":"102","author":"Gewillig","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2026.107589_bib0007","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ahj.2021.09.012","article-title":"Prevalent pharmacotherapy of US Fontan survivors: a study utilizing data from the MarketScan Commercial and Medicaid claims databases","volume":"243","author":"O'Byrne","year":"2022","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2026.107589_bib0008","article-title":"Clinical implications of progressive systemic ventricular dysfunction in adults with Fontan palliation","volume":"22","author":"Bai","year":"2025","journal-title":"Int J Cardiol Congenit Heart Dis"},{"key":"10.1016\/j.ahj.2026.107589_bib0009","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jacc.2020.05.059","article-title":"Relationship of ventricular morphology and atrioventricular valve function to long-term outcomes following Fontan procedures","volume":"76","author":"Moon","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107589_bib0010","article-title":"Echocardiographic indices of ventricular systolic function in adults with Fontan palliation: feasibility, reproducibility, and prognostic implications","author":"Aboelmaaty","year":"2025","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ahj.2026.107589_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107589_bib0012","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2333","volume":"24","author":"McDonagh","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2026.107589_bib0013","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijcard.2015.06.018","article-title":"Renin-angiotensin-aldosterone system genotype and serum BNP in a contemporary cohort of adults late after Fontan palliation","volume":"197","author":"Burchill","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2026.107589_bib0014","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004515","article-title":"Hemodynamics of Fontan failure: the role of pulmonary vascular disease","volume":"10","author":"Egbe","year":"2017","journal-title":"Circul Heart Fail"},{"key":"10.1016\/j.ahj.2026.107589_bib0015","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.ijcard.2012.04.015","article-title":"Sympathetic and vascular dysfunction in adult patients with Fontan circulation","volume":"167","author":"Lambert","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2026.107589_bib0016","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ejhf.2706","article-title":"Exercise-induced changes in pulmonary artery wedge pressure in adults post-fontan versus heart failure with preserved ejection fraction and non-cardiac dyspnoea","volume":"25","author":"Miranda","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2026.107589_bib0017","article-title":"2025 ACC\/AHA\/HRS\/ISACHD\/SCAI guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","author":"Gurvitz","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107589_bib0018","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jacc.2021.11.033","article-title":"Optimal background pharmacological therapy for heart failure patients in clinical trials: JACC review topic of the week","volume":"79","author":"Fiuzat","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107589_bib0019","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jchf.2020.10.002","article-title":"Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research Consortium","volume":"8","author":"Abraham","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ahj.2026.107589_bib0020","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1002\/ehf2.14524","article-title":"A scoring evaluation for the practical introduction of guideline-directed medical therapy in heart failure patients","volume":"10","author":"Matsukawa","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.ahj.2026.107589_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.102038","article-title":"The Mayo Adult Congenital Heart Disease (MACHD) registry and biobank","volume":"4","author":"Egbe","year":"2025","journal-title":"JACC Adv"},{"key":"10.1016\/j.ahj.2026.107589_bib0022","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.125.012908","article-title":"Feasibility, reproducibility, and prognostic value of exercise echocardiography for cardiac output reserve assessment in Fontan physiology","volume":"18","author":"Egbe","year":"2025","journal-title":"Circul Heart Fail"},{"key":"10.1016\/j.ahj.2026.107589_bib0023","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000696","article-title":"Evaluation and management of the child and adult with Fontan circulation: a scientific statement from the American Heart Association","volume":"140","author":"Rychik","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107589_bib0024","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00246-023-03332-5","article-title":"Experience with SGLT2 inhibitors in patients with single ventricle congenital heart disease and fontan circulatory failure","volume":"46","author":"Konduri","year":"2025","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.ahj.2026.107589_bib0025","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.jacc.2024.02.017","article-title":"Effect of sodium-glucose cotransporter 2 inhibitors in adults with congenital heart disease","volume":"83","author":"Neijenhuis","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107589_bib0026","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.124.012716","article-title":"Guideline-directed medical therapy use in the STRONG-HF trial","volume":"18","author":"Zhang","year":"2025","journal-title":"Circul Heart Fail"},{"key":"10.1016\/j.ahj.2026.107589_bib0027","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.009729","article-title":"A composite score summarizing use and dosing of evidence-based medical therapies in heart failure: a nationwide cohort study","volume":"16","author":"Johansen","year":"2023","journal-title":"Circul Heart fail"},{"key":"10.1016\/j.ahj.2026.107589_bib0028","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.47519","article-title":"Neighborhood-level socioeconomic status and prescription fill patterns among patients with heart failure","volume":"6","author":"Mukhopadhyay","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ahj.2026.107589_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100818","article-title":"Determinants of guideline-directed medical therapy implementation during heart failure hospitalization","volume":"3","author":"Margolin","year":"2024","journal-title":"JACC Adv"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870326002516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870326002516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:35:47Z","timestamp":1793280947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870326002516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":29,"alternative-id":["S0002870326002516"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107589","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guideline-directed medical therapy and clinical outcomes in adults with Fontan palliation and systemic ventricular systolic dysfunction","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107589","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107589"}}